Incidence and Predictors of Catheterization-Related Cerebral Infarction on Diffusion-Weighted Magnetic Resonance Imaging

Table 2

Baseline characteristics of the study subjects.

	All	CI	No CI
Age, yr	71.6 ± 8.7	74.1 ± 6.6	70.4 ± 9.4		0.04
Male, %	61.9	66.7	59.7	0.53
Hypertension, %	73.8	77.8	71.9	0.57
Dyslipidemia (LDL ≧ 140 mg/dL/statin user), %	45.2	63	36.8	0.04
LDL ≧ 140 mg/dL, %	10.7	14.8	8.8	0.46
Diabetes, %	42.9	55.6	36.8	0.11
Smoking, %	59.5	63	57.9	0.66
Family history, %	10.7	11.1	10.5	0.94
Prior stroke, %	14.3	18.5	12.3	0.45
Prior MI, %	26.2	29.6	24.6	0.62
MI within 7 days prior, %	6.0	11.1	3.5	0.17
EF < 40, %	13.1	22.2	8.8	0.09
PVD, %	28.6	40.7	22.8	0.09
CAD, %	60.7	77.8	52.6	0.03
Cre > 1.5 mg/dL, %	14.3	14.8	14.4	0.92
Severe aortic stenosis, %	11.9	3.7	15.8	0.11
AF, %	10.7	14.8	8.8	0.40
Preprocedural medication
Statin, %	38.1	51.9	31.6	0.09
ACE-I/ARB, %	47.6	51.9	45.6	0.59
Beta blocker, %	29.8	37	26.3	0.32
CCB, %	51.2	55.6	49.1	0.58
Antiplatelet, %	53.6	74	43.9	0.01
Anticoagulation, %	13.1	18.5	10.5	0.31

Included in multivariate analysis.
LDL: low-density lipoprotein; MI: myocardial infarction; PVD: peripheral vascular disease; CAD: coronary artery disease; AF: atrial fibrillation; ACE-I: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker.